NEOGENOMICS NEWS

NeoGenomics Announces the Opening of its
First International Laboratory near Geneva,
Switzerland to Support Clinical Trials

Read More

Comprehensive Immuno-Oncology Testing

Explore More CDx Options with All Currently Available
PD-L1 IVDs, Tumor Mutation Burden, MSI, and MMR

Learn More

Online%20test%20Ordering

What are the top five ways

Online Test Ordering

can improve your day and your workflow?

Answers Here

Pharma Services

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more 

NeoGenomics Industy Events

Upcoming Events

Meet with NeoGenomics at an upcoming tradeshow

Click here to view

Fourth Quarter and Full Year 2017 Financial Results

Date: February 21, 2018
Time: 10:00 am (America/New York)

See Webcast

HER-2%20Breast%20FISH

New Posters from ASH 2017

MDS Diagnosis, cfRNA and NGS, Liquid Biopsy for Myeloid Neoplasms, Clonal Hematopoiesis and MDS, and FLT3 Mutation in Acute Myeloid Leukemia

Read now

HER-2%20Breast%20FISH

Global Capabilities

Learn about our unique service offerings that are now available globally

Read now

KRAS%20BRAF%20EGFR%20Mutation

New Research Paper in Journal of Cancer

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy

Read now

KRAS%20BRAF%20EGFR%20Mutation

New Article in Springer Nature

Detecting BRAF, KRAS, and EGFR Mutations via NGS vs. PCR-based Kits

Read now

HER-2%20Breast%20FISH

NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

Read press release

HER-2%20Breast%20FISH

NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

Read press release

PPM1D-Mutation-Analysis

PPM1D Mutation Analysis

Regulator of TP53 relevant to MDS progression, solid tumors, and germline predisposition

Learn more

Universal%20Fusion

NPM1 MRD Analysis

High-sensitivity testing to detect minimal residual disease-related NPM1 mutations in AML

Learn more

NeoLab%20EGFR

NeoLABTM EGFR T790M Liquid Biopsy

Learn more

Accurate and sensitive detection of the EGFR T790M mutation using cell-free plasma DNA

PD-L1-22C3-IHC-for-Gastric%25252FGEA

PD-L1 22C3 IHC for Gastric/GEA

PD-L1 22C3 pharmDx™ for Gastric & Gastroesophageal Junction Adenocarcinoma (GEJ/GEA)

Learn more